Matthew D. Vesely

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

Matthew M. Gubin, Xiuli Zhang, Heiko Schuster et al. · Nature · 2014 · 2K citations · Full text

Life Sciences, Immunology, Oncology +10

Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting

Hirokazu Matsushita, Matthew D. Vesely, Daniel C. Koboldt et al. · Nature · 2012 · 1.3K citations · Full text

Medicine, Cancer Biology, Oncology +16

Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy

Matthew D. Vesely, Robert D. Schreiber · Annals of the New York Academy of Sciences · 2013 · 357 citations

Life Sciences, Immunology, Oncology +17

T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma

Alexander X. Lozano, Aadel A. Chaudhuri, Aishwarya Nene et al. · Nature Medicine · 2022 · 325 citations · Full text

Life Sciences, Immunology, Oncology +14

Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis

Jeremy B. Swann, Matthew D. Vesely, Anabel Silva et al. · Proceedings of the National Academy of Sciences · 2008 · 300 citations · Full text

Life Sciences, Immunology, Oncology +17